Atlas Trials

Extramedullary Disease in Multiple Myeloma

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Extramedullary Disease in Multiple Myeloma

RecordFirmDate
A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Relapsed Refractory Multiple Myeloma (RRMM) With Extramedullary Disease (EMD) and Paramedullary Disease (PMD) "PRIME-EMD-PMD" (NCT07382739)M.D. Anderson Cancer Center2026-03-31
External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease (NCT06572605)City of Hope Medical Center2025-08-29
Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease (NCT06627751)Roswell Park Cancer Institute2025-05-01

Track Extramedullary Disease in Multiple Myeloma automatically

Every clearance here is in the API, with alerts when new ones post.